🇺🇸 FDA
Patent

US 11865140

Restimulation of cryopreserved tumor infiltrating lymphocytes

granted A61KA61K2239/57A61K40/11

Quick answer

US patent 11865140 (Restimulation of cryopreserved tumor infiltrating lymphocytes) held by Iovance Biotherapeutics, Inc. expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Iovance Biotherapeutics, Inc.
Grant date
Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K2239/57, A61K40/11, A61K40/4271, A61P